These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

355 related articles for article (PubMed ID: 26678258)

  • 41. Recreational phenethylamine poisonings reported to a French poison control center.
    Le Roux G; Bruneau C; Lelièvre B; Bretaudeau Deguigne M; Turcant A; Harry P; Boels D
    Drug Alcohol Depend; 2015 Sep; 154():46-53. PubMed ID: 26205314
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Poisoning in the United States: 2012 emergency medicine report of the National Poison Data System.
    Dart RC; Bronstein AC; Spyker DA; Cantilena LR; Seifert SA; Heard SE; Krenzelok EP
    Ann Emerg Med; 2015 Apr; 65(4):416-22. PubMed ID: 25523411
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Acute poisoning in pregnancy: a province-wide perspective from a poison center.
    Zipursky JS; Yaphe H; Hudson H; Wong A; Thompson M
    Clin Toxicol (Phila); 2020 Jul; 58(7):736-741. PubMed ID: 31621422
    [No Abstract]   [Full Text] [Related]  

  • 44. The rise of new psychoactive substance use in Australia.
    Burns L; Roxburgh A; Matthews A; Bruno R; Lenton S; Van Buskirk J
    Drug Test Anal; 2014; 6(7-8):846-9. PubMed ID: 24599890
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Examination of Synthetic Cannabinoid and Cathinone Use among a Drug-Using Offender Sample, 2013-2015.
    Smith KE; Bunting AM; Staton M; Walker R; Shalash S; Winston E; Pangburn K
    J Psychoactive Drugs; 2017; 49(5):436-445. PubMed ID: 28813207
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Poisoning in the elderly: characterization of exposures reported to a poison control center.
    Kroner BA; Scott RB; Waring ER; Zanga JR
    J Am Geriatr Soc; 1993 Aug; 41(8):842-6. PubMed ID: 8340563
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Clinical toxicity following analytically confirmed use of the synthetic cannabinoid receptor agonist MDMB-CHMICA. A report from the Identification Of Novel psychoActive substances (IONA) study.
    Hill SL; Najafi J; Dunn M; Acheampong P; Kamour A; Grundlingh J; Blain PG; Thomas SH
    Clin Toxicol (Phila); 2016 Sep; 54(8):638-43. PubMed ID: 27251903
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Carbon monoxide exposures in New York City following Hurricane Sandy in 2012.
    Chen BC; Shawn LK; Connors NJ; Wheeler K; Williams N; Hoffman RS; Matte TD; Smith SW
    Clin Toxicol (Phila); 2013 Nov; 51(9):879-85. PubMed ID: 24059251
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Poison exposures in young Israeli military personnel: a National Poison Center Data analysis.
    Lavon O; Bentur Y
    Clin Toxicol (Phila); 2017 Jun; 55(5):322-325. PubMed ID: 28084844
    [TBL] [Abstract][Full Text] [Related]  

  • 50. There's something about Molly: The underresearched yet popular powder form of ecstasy in the United States.
    Palamar JJ
    Subst Abus; 2017; 38(1):15-17. PubMed ID: 27925866
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Narrative Review of the Pharmacodynamics, Pharmacokinetics, and Toxicities of Illicit Synthetic Cannabinoid Receptor Agonists.
    Lea Houston M; Morgan J; Kelso C
    Mini Rev Med Chem; 2024; 24(1):92-109. PubMed ID: 37190813
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Attitudes and Beliefs About New Psychoactive Substance Use Among Electronic Dance Music Party Attendees.
    Palamar JJ; Acosta P; Cleland CM
    Subst Use Misuse; 2018 Feb; 53(3):381-390. PubMed ID: 28777688
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Typology of new psychoactive substance use among the general Australian population.
    Sutherland R; Peacock A; Roxburgh A; Barratt MJ; Burns L; Bruno R
    Drug Alcohol Depend; 2018 Jul; 188():126-134. PubMed ID: 29775956
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Correlates of new psychoactive substance use among a self-selected sample of nightclub attendees in the United States.
    Palamar JJ; Barratt MJ; Ferris JA; Winstock AR
    Am J Addict; 2016 Aug; 25(5):400-7. PubMed ID: 27419383
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Evaluation of changes in poisoning in young children: 2000 to 2010.
    Spiller HA; Beuhler MC; Ryan ML; Borys DJ; Aleguas A; Bosse GM
    Pediatr Emerg Care; 2013 May; 29(5):635-40. PubMed ID: 23603655
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Pattern of ziprasidone exposures reported to Texas poison centers, 2001-2005.
    Forrester MB
    Hum Exp Toxicol; 2008 Apr; 27(4):355-61. PubMed ID: 18684807
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Human bromethalin exposures reported to a U.S. Statewide Poison Control System.
    Huntington S; Fenik Y; Vohra R; Geller RJ
    Clin Toxicol (Phila); 2016 Mar; 54(3):277-81. PubMed ID: 26860212
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Geographic distribution of synthetic cannabinoid exposures reported to Texas poison centers.
    Forrester MB; Haywood T
    Am J Drug Alcohol Abuse; 2012 Nov; 38(6):603-8. PubMed ID: 22571605
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Clinical and analytical experience of the National Poison Control Centre with synthetic cannabinoids.
    Vučinić S; Kilibarda V; Đorđević S; Đorđević D; Perković-Vukčević N; Vuković-Ercegović G; Antonijević B; Ćurčić M; Antonijević E; Brajković G
    Arh Hig Rada Toksikol; 2018 Jun; 69(2):178-185. PubMed ID: 29990297
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Raising awareness of new psychoactive substances: chemical analysis and in vitro toxicity screening of 'legal high' packages containing synthetic cathinones.
    Araújo AM; Valente MJ; Carvalho M; Dias da Silva D; Gaspar H; Carvalho F; de Lourdes Bastos M; Guedes de Pinho P
    Arch Toxicol; 2015 May; 89(5):757-71. PubMed ID: 24903018
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.